For many women, monthly periods bring much more than minor inconveniences. They can feel like a debilitating ordeal, marked ...

It’s important for clinicians to assess patients undergoing percutaneous coronary intervention (PCI) for both anemia and chronic kidney disease (CKD).

Anemia, characterized by insufficient red blood cells or hemoglobin, leads to fatigue and potential heart complications.

BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 ...

A Northeast Ohio woman and a 22-year-old man from UAE are among the first patients to receive the innovative CRISPR treatment ...

Anemia is a common condition and has many causes, one of which is hemolytic disease of the fetus and newborn (HDFN), a ...

Although sickle cell disease (SCD) is not as widespread in the Philippines compared to other populations, it is still worth ...

New findings reveal that combining erythropoiesis-stimulating agents with ruxolitinib maintains efficacy in treating ...

Panelists discuss how to select among the four available JAK inhibitors (Ruxolitinib, Fedratinib, Pacritinib, and Momelotinib) based on patient-specific factors such as anemia, thrombocytopenia, and ...

Our knowledge of the effects of space and low gravity on blood cells, clotting, and anemia continues to expand, but further ...

Beam reports breakthrough results from BEAM-101's early-stage trial for severe sickle cell disease. Read more here.

Some doctors told him he'd live with the disease forever, but Khaled Alsheebani never stopped believing treatments would ...